Genprex, Inc. (GNPX) NASDAQ
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Genprex, Inc.
Address
3300 Bee Cave Road
Austin, TX 78746
United States of America (the)
Phone
877 774 4679
Website
Sector
Healthcare
Industry
Biotechnology
Employees
13
First IPO Date
March 29, 2018
Key Executives
| Name | Title | Pay | Year Born |
| Ryan Confer | President, Chief Executive Officer, Chief Financial Officer & Director | 638,421 | 1982 |
| Mark S. Berger | Chief Medical Officer | 631,319 | 1955 |
| David Schloss | Senior Vice President of Human Resources | 0 | N/A |
| Greg Jancarik | Senior Director & Corporate Controller | 0 | N/A |
| Thomas C. Gallagher | Senior Vice President of Intellectual Property & Licensing | 0 | N/A |
| Celina Laney | Chief of Staff | 0 | N/A |
| Suzanne Thornton-Jones | Senior Vice President of Regulatory Affairs & Quality | 0 | N/A |
Description
Genprex, Inc. is a biotechnology firm specializing in gene therapy, with its primary focus on advancing treatments through clinical stages. Their mission revolves around developing innovative therapies for patients battling cancer and diabetes. Leading their product pipeline is REQORSA (GPX-001), a flagship gene therapy candidate specifically designed to target both non-small cell lung cancer and small cell lung cancer. In addition, Genprex is progressing GPX-002, another gene therapy at the preclinical stage, intended for the management of diabetes. The company was established in 2009 and operates from its corporate headquarters located in Austin, Texas.
